logo
Is Flowers Foods (FLO) the Best Dividend Growth Stock with High Yields?

Is Flowers Foods (FLO) the Best Dividend Growth Stock with High Yields?

Yahoo14-05-2025
We recently published a list of the . In this article, we are going to take a look at where Flowers Foods, Inc. (NYSE:FLO) stands against other best dividend growth stocks.
Dividend-paying stocks have been gaining popularity among investors due to their long-term advantages. According to Jeremy Zirin, who leads the US equity team for private clients at UBS Asset Management, companies with a consistent track record of increasing dividends are a smart choice for investors seeking a balanced approach in the current market environment. When markets dipped in April after President Donald Trump announced new tariff policies, investors gravitated toward high-yield dividend stocks. However, as trade tensions began to ease and negotiations progressed, markets recovered. Stocks surged particularly after the US and China agreed to temporarily reduce tariffs. He made the following comment about dividend stocks:
'The higher-dividend-yielding strategies tend to do better when markets are in real turmoil and declining, but if there's more chop, more volatility and potentially upside … you don't want to be overly defensive.'
Historically, companies that consistently increase their dividends have tended to be less volatile and often delivered stronger returns than the broader market, including benchmarks like the S&P Equal Weight Index. According to a report by Guggenheim, from May 2005 through December 2024, firms that either initiated or raised their dividends generated an average annual return of 10.5%. In contrast, companies that cut or suspended their payouts posted just 5.5% annually. The overall market returned 10.4% during this timeframe, slightly behind the dividend growers. The report also highlighted that dividend growth strategies have historically performed well in both rising and falling markets, making them an attractive option for investors focused on long-term gains and downside protection.
According to a report by S&P Global, the growth of global dividend payments had been slowing since the post-COVID recovery, but that trend reversed last year. In 2024, the growth rate unexpectedly accelerated to 8%, with shareholders receiving approximately $180 billion more than the previous year. This increase came as a surprise given the persistent geopolitical and economic challenges. The report also highlighted that several sectors and regions saw record dividend initiations, including the US technology, media, and telecom (TMT) sector, banks in Italy and Spain, Japan's automotive industry, and a general rise in payouts from Mainland China. Even with extreme price fluctuations, dividend payments from the oil and gas sector remained strong. Looking ahead, the report suggested that this high level of dividends is likely to hold steady, with global payouts expected to remain at $2.3 trillion in 2025.
With growing investor appetite for dividend-paying stocks, many companies have responded by gradually increasing their dividend payouts. A report by Janus Henderson revealed that global dividend payments reached a record $1.75 trillion in 2024, reflecting a 6.6% rise on an underlying basis. The overall growth rate came in at 5.2%, slightly held back by a drop in special one-time dividends and the effect of a stronger U.S. dollar. Out of the 49 countries covered in the report, 17—including major economies such as the US, Canada, France, Japan, and China—posted record-high dividend levels. In total, 88% of companies either raised or held their dividends steady over the year.
A female baker in a spotless kitchen carefully decorating a cake.
For this list, we screened for dividend stocks with yields higher than 3% as of May 13. From this group, we further refined our selection criteria by identifying stocks with a dividend growth streak of 10 years or more. The stocks are ranked in ascending order of their dividend yields.
At Insider Monkey, we are obsessed with hedge funds. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points ().
Dividend Yield as of May 13: 5.58%
Flowers Foods, Inc. (NYSE:FLO) ranks seventh on our list of the best dividend stocks with high yields. The Georgia-based bakery products company reported that its first-half performance in 2025 is expected to benefit from recent business wins, cost-cutting efforts, favorable pricing, and lower commodity costs. However, management cautioned that these tailwinds may taper off in the second half, with rising input costs and ongoing category challenges likely to weigh on results. The company also expressed optimism about its planned acquisition of Simple Mills, which is expected to enhance adjusted EBITDA in 2025 but may temporarily reduce adjusted EPS.
In the fourth quarter of 2024, Flowers Foods, Inc. (NYSE:FLO) posted revenue of $1.11 billion, down 1.6% year-over-year and below analysts' forecasts by $19.7 million. However, net income rose 20.9% to $43.1 million, representing nearly 4% of sales. Adjusted EBITDA increased by 6.3% to $102.4 million, accounting for 9.2% of net sales and reflecting a 70-basis point margin improvement.
For fiscal year 2024, Flowers Foods, Inc. (NYSE:FLO)'s operating cash flow rose to $412.7 million, up $63.3 million from the prior year. The company returned $203 million to shareholders through dividends. The company's quarterly dividend comes in at $0.24 per share and has a dividend yield of 5.58%, as of May 13. It has been rewarding shareholders with growing dividends for the past 22 years.
Overall, FLO ranks 7th on our list of the best dividend growth stocks with high yields. While we acknowledge the potential of FLO as an investment, our conviction lies in the belief that some deeply undervalued dividend stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for a deeply undervalued dividend stock that is more promising than FLO but that trades at 10 times its earnings and grows its earnings at double digit rates annually, check out our report about the .
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at .
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Merck & Co., Inc. (MRK) Impresses Jim Cramer With Its Toughness
Merck & Co., Inc. (MRK) Impresses Jim Cramer With Its Toughness

Yahoo

time2 minutes ago

  • Yahoo

Merck & Co., Inc. (MRK) Impresses Jim Cramer With Its Toughness

We recently published . Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer recently discussed. Merck & Co., Inc. (NYSE:MRK)'s shares have lost 16% year-to-date as investors continue to be disappointed by the dropping revenue of its GARDASIL HPV drug in China. They are also worried about the patent expiration of the firm's mega cancer drug KEYTRUDA and wondering whether Merck & Co., Inc. (NYSE:MRK) will be able to follow up with an equally successful successor. However, the shares did gain 3% this week after Pfizer announced that its bladder cancer drug PADCEV improves survival rates when paired with KEYTRUDA. Cramer was impressed as he commented: 'Look at Merck. I mean, Saint Merck. What a tough, what a tough.' Photo by National Cancer Institute on Unsplash Here are his earlier comments about Merck & Co., Inc. (NYSE:MRK): 'Well, this GARDASIL, when is it? The Chinese are not really helping them sell, because you would have thought the Chinese would. . .and then you've got the KEYTRUDA, you know the patent cliff coming up. . .it's amazing, but they are talking about their animal division. When you're talking about your animal division you don't have enough [inaudible] to talk.' While we acknowledge the potential of MRK as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio

Pfizer Inc. (PFE) Comes Up With A Good Thing But No One Cares, Laments Jim Cramer
Pfizer Inc. (PFE) Comes Up With A Good Thing But No One Cares, Laments Jim Cramer

Yahoo

time2 minutes ago

  • Yahoo

Pfizer Inc. (PFE) Comes Up With A Good Thing But No One Cares, Laments Jim Cramer

We recently published . Pfizer Inc. (NYSE:PFE) is one of the stocks Jim Cramer recently discussed. Pfizer Inc. (NYSE:PFE)'s shares jumped by 1.8% earlier this week after the firm announced that its bladder cancer drug Padcev helped improve bladder cancer survival rates when combined with Merck's well-known cancer treatment, KEYTRUDA. The gains were a much-needed boost to the stock, which is still down by 5.6% year-to-date, as the firm has struggled to grow revenue in a turnaround effort led by CEO Albert Bourla. Cramer lamented that Pfizer Inc. (NYSE:PFE)'s stock didn't move higher on the news: 'Bladder cancer. Now that is left over from the Seagen. The Seagen deal, that was supposed to be very, very important. They spent a fortune on Seagen. And I thought the [inaudible] I thought would be a little more just positive. People are not buying the stock. People just feel like, Pfizer comes up with good thing, good thing, good thing, and no one seems to, David, take it as gospel.' Copyright: kadmy / 123RF Stock Photo Cramer discussed Pfizer Inc. (NYSE:PFE) ahead of its earnings: 'There's another one, that I'm not so sure of, reporting at the same time, though, Pfizer. We need to see some really dramatic results here from the clinical trials like the ones that Pfizer picked up when they bought the Seagen at the end of 2023. It's enough time to see more than we've seen already, I gotta tell you that. And they better hurry up because the shareholder base is getting very restive, and who knows what the president has… against this industry.' While we acknowledge the potential of PFE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Sandisk guidance, Evolv Technologies earnings, Flowers Foods outlook
Sandisk guidance, Evolv Technologies earnings, Flowers Foods outlook

Yahoo

time2 minutes ago

  • Yahoo

Sandisk guidance, Evolv Technologies earnings, Flowers Foods outlook

Here are some of the stories Wall Street is watching on Friday, Aug. 15. Sandisk (SNDK) shares are slipping after issuing what some analysts are calling conservative fiscal Q1 guidance. Evolv Technologies (EVLV) is seeing its shares rise on Q2 results. Flowers Foods (FLO) cut its full-year outlook, with Chairman and CEO Ryals McMullian saying, "Macroeconomic uncertainty and shifting consumer demand have continued to pressure the bread category." Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute. It's time for your Yahoo! Finance's market minute stocks trading mixed, but on track for weekly gains as investors increasingly price in a September rate cut. Computer hardware and storage company SanDisk's falling as analysts dubbed the firm's guidance conservative. Firm sees first quarter EPS of 70 cents to 90 cents versus the 91 cents estimated. Gross margins forecast also coming in below estimates. Shares of security company Evolv Technologies rising after reporting better than expected results and raising its full-year revenue forecast. Lake Street Capital upgrading that stock to buy from hold, citing the firm growing new accounts and expanding relationships. Baked foods producer Flower Foods is falling after cutting its full-year outlook and reporting second quarter revenue that did miss estimates. Management citing softness and bread sales and an intensifying competitive environment. That's your Yahoo! Finance market minute. For more on what's trending on Yahoo! Finance, scan the QR code below. Related Videos Consumer health is 'relatively sunny,' but some risks persist Here's how Americans are feeling about their finances now What economists are saying about inflation now Intel & Trump, Opendoor CEO resigns, EV makers & EV tax credits Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store